T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$874M |
| 2 |
Starbucks
SBUX
|
+$860M |
| 3 |
Becton Dickinson
BDX
|
+$660M |
| 4 |
NiSource
NI
|
+$655M |
| 5 |
Hilton Worldwide
HLT
|
+$624M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.72B |
| 2 |
Marvell Technology
MRVL
|
+$1.06B |
| 3 |
Thermo Fisher Scientific
TMO
|
+$791M |
| 4 |
McKesson
MCK
|
+$738M |
| 5 |
WCN
Waste Connections
WCN
|
+$656M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.48% |
| 2 | Healthcare | 18.36% |
| 3 | Consumer Discretionary | 13.95% |
| 4 | Industrials | 10.53% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Eagle Materials
EXP
$6.47B
| – | – |
-14,815
| Closed | -$3.29M |
|
702
First Advantage
FA
$3.61B
| – | – |
-2,168,792
| Closed | -$30.6M |
|
|
FARO
703
DELISTED
Faro Technologies
FARO
| – | – |
-1,442,512
| Closed | -$39.4M |
|
704
Flywire
FLYW
$2.12B
| – | – |
-545,601
| Closed | -$5.18M |
|
705
Fortinet
FTNT
$118B
| – | – |
-463,877
| Closed | -$44.7M |
|
706
Grid Dynamics Holdings
GDYN
$632M
| – | – |
-189,962
| Closed | -$2.97M |
|
|
GMS
707
DELISTED
GMS Inc
GMS
| – | – |
-1,333,127
| Closed | -$97.5M |
|
708
Hudbay
HBM
$12.4B
| – | – |
-4,304,733
| Closed | -$32.7M |
|
709
Home Depot
HD
$342B
| – | – |
-1,308
| Closed | -$480K |
|
710
Hormel Foods
HRL
$13.4B
| – | – |
-11,487
| Closed | -$356K |
|
711
HUB Group
HUBG
$2.46B
| – | – |
-935,026
| Closed | -$34.8M |
|
|
BRSL
712
Brightstar Lottery PLC
BRSL
$2.08B
| – | – |
-1,095,495
| Closed | -$17.8M |
|
713
Insmed
INSM
$28.9B
| – | – |
-1,476,948
| Closed | -$113M |
|
714
Krystal Biotech
KRYS
$9.85B
| – | – |
-185,550
| Closed | -$33.5M |
|
715
LCI Industries
LCII
$2.6B
| – | – |
-83,050
| Closed | -$7.26M |
|
716
Monro
MNRO
$359M
| – | – |
-2,741,498
| Closed | -$39.7M |
|
|
717
Marvell Technology
MRVL
$195B
| – | – |
-17,244,465
| Closed | -$1.06B |
|
718
Insperity
NSP
$1.92B
| – | – |
-520,637
| Closed | -$46.5M |
|
719
Orion
OEC
$364M
| – | – |
-318,376
| Closed | -$4.12M |
|
720
Phreesia
PHR
$758M
| – | – |
-298,891
| Closed | -$7.64M |
|
721
Packaging Corp of America
PKG
$22.8B
| – | – |
-78,356
| Closed | -$15.5M |
|
722
Privia Health
PRVA
$2.75B
| – | – |
-219,058
| Closed | -$4.92M |
|
723
PTC Therapeutics
PTCT
$6.06B
| – | – |
-174,088
| Closed | -$8.87M |
|
724
RH
RH
$3.41B
| – | – |
-81,623
| Closed | -$19.1M |
|
725
Shake Shack
SHAK
$2.94B
| – | – |
-283,717
| Closed | -$25M |
|
Similar funds
T. Rowe Price Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Investment Management held 750 positions worth $158B, up 4.8% from $151B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Investment Management's Q2 2025 filing shows 94 new, 316 increased, 272 reduced and 66 closed positions. Its largest new stake was Analog Devices: 1,692,080 shares worth $403M. The largest sale was Fortive, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q2 2025 buy was Analog Devices: 1,692,080 shares worth $403M.
- T. Rowe Price Investment Management added most to Amazon in Q2 2025, an estimated $874M increase.
- T. Rowe Price Investment Management's biggest Q2 2025 reduction was Fortive, cutting an estimated $1.72B.
- T. Rowe Price Investment Management fully exited Marvell Technology in Q2 2025, selling an estimated $1.06B.
- T. Rowe Price Investment Management's ten largest holdings make up 21% of its $158B portfolio in Q2 2025.
- T. Rowe Price Investment Management opened 94 new positions and closed 66 in Q2 2025.
- T. Rowe Price Investment Management's portfolio value rose 4.8% quarter-over-quarter to $158B.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.